Used in pharmaceutical research as a potent and selective inhibitor targeting specific kinase pathways involved in inflammatory and immune-mediated diseases. Shows promise in the development of treatments for autoimmune conditions such as rheumatoid arthritis and psoriasis due to its ability to modulate cellular signaling with high specificity. Its structure allows for improved metabolic stability and bioavailability, making it a valuable candidate in preclinical studies for oral therapeutics. Also employed in structure-activity relationship (SAR) studies to optimize drug potency and reduce off-target effects in next-generation inhibitors.